Skip to main content
Premium Trial:

Request an Annual Quote

Good News, and a Blast from the Past

Sure, it's probably been a long time since you've thought about Human Genome Sciences. But Venter's former business partner just announced positive results of its anthrax drug in animal studies, reports this article in the Wall Street Journal. The company said that "a single dose of its anthrax-fighting drug ABthrax -- without benefit of any additional antibiotics -- improved survival rates from inhalation of deadly anthrax spores by up to 64% in test subjects," according to the article.

 

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.